Table 3.
The role of KLF5 in different types of cancer
Cancers | Genetic and expression | Function | References |
---|---|---|---|
Intestine and colon | mRNA expression is decreased in APCmin mouse adenomas and familial adenomatous polyposis | Promotes cell proliferation | [51, 73, 74, 79, 101] |
Breast | Gene copy number loss. mRNA is low in ER + cancer cell lines, high in ER-tumors | Promotes MCF7 xenograft growth | [36, 84, 110] |
Prostate | Gene copy number loss. mRNA is lost in some cancer cell lines | Inhibits DU145 and 22Rv1 colony formation | [78, 111] |
Overexpression in some prostate cancers | |||
Bladder | mRNA is upregulated and downregulated in cancer cell lines but not in tumor samples | Promotes TSU-Pr1 xenograft growth | [20, 40] |
Leukemia | mRNA is upregulated and downregulated in cancer cell lines and acute lymphoblastic leukemia by Northern blot | Promotes EU-4 resistance to doxorubicin | [45] |
Esophageal | mRNA level is high in stem-like cancer cells by qRT-PCR | Inhibits cell proliferation, survival, and invasion. Promotes basal cell proliferation in KLF5 Tg mice | [77, 102, 112] |
Salivary gland | Gene copy number gain by CGH | [108] | |
Gastric cancer | Protein expression is high in early-staged, lymph node metastasis negative, and small sized tumors by IHC | [109] | |
Nasopharyngeal | mRNA is down-regulated by microarray | [138]. | |
Melanoma | mRNA is down-regulated in two Ras mutated cancer cell lines by microarray | [139] |